Personalized Medicines Market Demands and Value Predication 2023-2029 by Key Players | 3G Biotech , Quest Diagnostics , Laboratory Corporation of America , Abbott

****Everything You Need to Know About Personalized Medicines everything is Here....!

The Comprehensive study on Personalized Medicines Market includes historical data as well as share, size, and projection information for the major players, geographies, applications, and product categories for the years 2023 to 2029. The Market study includes comprehensive insights on the competitive environment, description, broad product portfolio of key players, SWOT analysis, and significant business strategy implemented by rivals, revenue, Porters Five Forces Analysis, and sales projections. The report also features an impact analysis of the market dynamics, highlighting the factors currently driving and limiting market growth, and the impact they could have on the short, medium, and long-term outlook. The main goal of the paper is to further illustrate how the latest scenario, the economic slowdown, and war events effect the market for Personalized Medicines.

Personalized Medicines Market is growing at a +7.9% CAGR during the forecast period 2023-2029. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market.

Click the link to get a free sample copy of the report :

https://www.marketintelligencedata.com/reports/8522010/global-personalized-medicines-market-growth-status-and-outlook-2022-2028/inquiry?Mode=74Sayali

(*If you have any special requirements, please let us know and we will provide you with the report as you wish.)

The Top Key Players profiled in the report:

3G Biotech, Quest Diagnostics, Laboratory Corporation of America, Abbott, Agendia NV, Asuragen Inc, Becton Dickinson, CardioDx Inc., Foundation Medicine, Qiagen, Siemens Healthcare, Amgen, Bristol-Myers Squibb, GE Healthcare, Pfizer, Sanofi, 23andMe, Illumina

Industry News:

In July 2023, 23andMe released a new Simvastatin Medication Insight report, part of a suite of 23andMe reports that look into how genetics can impact the response to certain medications for people, as well as their chance of possible side effects. The Simvastatin Medication Insight report looks at individual responses to simvastatin, a statin drug for lowering blood cholesterol, which is also known by brand names like Zocor and Flolipid

In June 2023, Qiagen announced that the 'QCI Interpret' software had been selected by the Danish National Genome Center for providing sequencing-based solutions for cancer patients. The variant interpretation and reporting software had been chosen for interpreting oncology results extracted from whole-genome sequencing data. This development is part of Denmark's personalized medicine strategy for offering WGS as the standard-of-care for relevant patient groups

In June 2023, GE Healthcare showcased its latest solutions in the areas of precision care and personalized medicine at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2023 annual meeting. In the personalized medicine area, the company launched the SIGNA PET/MR system, which has been designed to aid clinicians in seeing the smallest lesions, research new tracers, and plan more accurate treatment paths for each patient

In June 2023, Illumina launched its new PrimateAI-3D AI algorithm, which predicts disease-causing genetic mutations in patients with a high accuracy. The algorithm uses deep neural network architectures and is trained on genome sequences. PrimateAI-3D aims to address the challenges facing the successful implementation of personalized genomic medicine through offering accurate predictions regarding disease-causing variants

Personalized Medicines Market Segmentation:

The major types of market are:

PM Diagnostics

PM Therapeutics

Personalized Medical Care

Personalized Nutrition & Wellness

The major applications in the market are:

Hospitals Pharmacies

Retail Pharmacies

Dietary Care Centers

Others

Based on geography, the global market for Personalized Medicines and Disruptions has been segmented as follows:

North America - USA, Canada, Mexico
Europe - Germany, France, UK, Italy, Spain
South America - Brazil, Colombia, Argentina, Chile
Asia Pacific includes Japan, China, Korea, India and Southeast Asia.

North America accounted for the largest market share of 48.14% in 2022. This is attributive to the support by research institutes and the pharmaceutical giants. Personalized medicine is now preferred for all kinds of diseases and therefore is part of research on any given disease and drug discovery. There are emerging advancements in personalized medicine for diagnostics in the region. For instance, in January 2021, Illumina, Inc. develops the TruSight Oncology 500 (TSO 500) assay that uses nucleic acids from tumor region and capably identifies as many as 523 cancer biomarkers.

Asia Pacific is projected to grow at the fastest CAGR of 8.51% over the forecast period due to increased demand for personalized medicine in diagnostics and the growing demand for novel therapeutic drugs to fight increased incidence of diseases in the region.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Personalized Medicines
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
Competitive Assessment: In-depth assessment of the Personalized Medicines market strategies, geographic and business segments of the leading players in the market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Personalized Medicines

Take a look at the full report with detailed TOC here:

https://www.marketintelligencedata.com/reports/8522010/global-personalized-medicines-market-growth-status-and-outlook-2022-2028?Mode=74Sayali

Some of the key questions scrutinized in the study are:

Which companies are expanding litanies of products with the aim to diversify product portfolio?
Which companies have drifted away from their core competencies and how have those impacted the strategic landscape of the Personalized Medicines market?
Which companies have expanded their horizons by engaging in long-term societal considerations?
Which firms have bucked the pandemic trend and what frameworks they adopted to stay resilient?
What are the marketing programs for some of the recent product launches?

Reasons for buying this report:

It offers an analysis of changing competitive scenario.
For making informed decisions in the businesses, it offers analytical data with strategic planning methodologies.
It offers seven-year assessment of Personalized Medicines Market.
It helps in understanding the major key product segments.
Researchers throw light on the dynamics of the market such as drivers, restraints, trends, and opportunities.
It offers regional analysis of Personalized Medicines Market along with business profiles of several stakeholders.
It offers massive data about trending factors that will influence the progress of the Personalized Medicines Market.

In the end, the Personalized Medicines Market report includes investment come analysis and development trend analysis. The present and future opportunities of the fastest growing international industry segments are coated throughout this report. This report additionally presents product specification, manufacturing method, and product cost structure, and price structure.

Buy Latest Version of Report :

https://www.marketintelligencedata.com/report/purchase/8522010?mode=su?Mode=74Sayali

We offer customization on the Personalized Medicines market report based on specific client requirements:

20% free customization.
Five Countries can be added as per your choice.
Five Companies can add as per your choice.
Free customization for up to 40 hours.
After-sales support for 1 year from the date of delivery.

Thank you for your interest in the Personalized Medicines Market research publications; you can also get individual chapters or regional/country report versions such as Germany, France, China, Latin America, GCC, North America, Europe or Asia……

About Us:
Market intelligence data is a global front-runner in the research industry, offering contextual and data-driven research services to customers. Customers are supported in creating business plans and attaining long-term success in their respective marketplaces by the organization. The industry provides consulting services, Market Intelligence Data research studies, and customized research reports.

Contact us:

Irfan Tamboli (Head of Sales) - market intelligence data

Phone: +1 (704) 266-3234 | +91-750-707-8687

Mail to: sales@marketintelligencedata.com

This release was published on openPR.